| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.14 | 0.3 |